Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Zura Bio Limited (ZURA)
USD5.35
+0.29 (+5.73%)
US NASDAQ Healthcare Biotechnology
Address
4225 Executive Square 92037
San Diego, CA, US
San Diego, CA, US
CEO
Sandeep C. Kulkarni
Website
zurabio.com
IPO
2023-03-21
CIK 1855644 ISIN KYG9TY5A1016
Also trades on
Frankfurt Stock Exchange · 94E.F (EUR)
NASDAQ Capital Market · ZURA (USD)
Description
Zura Bio Limited is a clinical-stage biotechnology company headquartered in San Diego, California, dedicated to pioneering new therapeutic solutions for immune system and inflammatory diseases. Its key product candidates include ZB-168, an anti-IL7Rα inhibitor engineered to address conditions influenced by the IL7 and TSLP biological pathways. The company is also advancing Torudokimab, a monoclonal antibody that neutralizes IL-33, which is currently in Phase 2 clinical development.
News Sentiment (7d)
Based on only 1 article — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD5.35
+0.29 (+5.73%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
1M
Beta
0.03
Float Shares
36.14M
Free Float %
55.6%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.84% | -3.06% | -15.93% | -23.51% | +2.59% | -9.35% | +283.06% | -21.36% | -34.39% | -34.39% | -34.39% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (7 ratings, all time)
Buy
Price Targets & DCF
Current price
5.35
Low
15.00
+180.4%
Consensus
15.00
+180.4%
Median
15.00
+180.4%
High
15.00
+180.4%
DCF (Unlevered)
1.16
-78.3%
DCF (Levered)
1.16
-78.3%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 6 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | 1 |
15.00
+180.4%
|
| Last Year | 1 |
15.00
+180.4%
|
| All Time | 4 |
9.50
+77.6%
|
Quality scores
Altman Z-Score
13.74
Safe zone
Piotroski F-Score
2 / 9
Weak
MOAT Score
3 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
3 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%—
-
EPS growth Biotechnology: +29.7%-76.7% Q1'26: +18.5% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%—
-
EBIT margin Biotechnology: +0.0%—
-
ROIC Biotechnology: -16.1%— Q1'26: +1,172.6% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+25.4% Q1'26: +71.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×0.00× Q1'26: 0.00× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 6 Rev. Ana. 4 EPS Ana. |
Dec 2027 6 Rev. Ana. 4 EPS Ana. |
Dec 2028 5 Rev. Ana. 6 EPS Ana. |
Dec 2029 2 Rev. Ana. 4 EPS Ana. |
Dec 2030 2 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
—
|
—
|
8.33M
8.33M – 8.33M
|
10.71M
10.71M – 10.71M
+28.6% YoY
|
8.33M
8.33M – 8.33M
-22.2% YoY
|
16.67M
16.67M – 16.67M
+100.0% YoY
|
171.72M
171.72M – 171.72M
+930.3% YoY
|
| EBITDA |
-55.18M
|
-75.20M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EBIT |
-55.19M
|
-75.25M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| Net Income |
-52.40M
est: -50.02M (-4.8%)
|
-68.65M
est: -74.86M (+8.3%)
|
-75.49M
-88.70M – -55.59M
-0.8% YoY
|
-75.75M
-83.02M – -13.24M
-0.4% YoY
|
-114.35M
-121.02M – -56.35M
-51.0% YoY
|
-101.69M
-101.69M – -101.69M
+11.1% YoY
|
-71.56M
-71.56M – -71.56M
+29.6% YoY
|
| SGA |
30.79M
|
33.16M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EPS |
-0.60
est: -0.67 (+9.9%)
|
-1.06
est: -0.80 (-33.3%)
|
-0.78
-0.94 – -0.59
+2.0% YoY
|
-0.69
-0.88 – -0.14
+11.4% YoY
|
-0.87
-1.29 – -0.60
-25.4% YoY
|
-1.08
-1.08 – -1.08
-24.9% YoY
|
-0.76
-0.76 – -0.76
+29.6% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-06 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-05 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-04 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-01 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-30 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-29 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-28 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-27 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-24 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-23 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
Owner's Earnings history not available.
Owner alignment
Owner's Earnings TTM
—
OE per share TTM
—
Owner's Yield
—
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
—
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
7
Total invested
2.61M
Insider transactions (90d)
0
Beneficial owners (>5%)
3
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ADAR1 Capital Management, LLC | 3.33M | 5.10% | — | 3.33M | — | 3.33M | OO | Texas | 2024-11-14 | ↗ |
| 2 | Daniel Schneeberger | 3.33M | 5.10% | — | 3.33M | — | 3.33M | IN | Texas | 2024-11-14 | ↗ |
| 3 | ADAR1 Capital Management GP, LLC | 2.96M | 4.53% | — | 2.96M | — | 2.96M | OO | Texas | 2024-11-14 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
7
-73 vs prev Q
New positions
2
Closed positions
69
Increased
2
Reduced
3
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | SUVRETTA CAPITAL MANAGEMENT, LLC | 5.57M +94.1K (+1.7%) | 29.17M +5.5M (+23.1%) | 5.89% +0.083 pp | 0.60% -0.009 pp | USD6.07 -13.7% | 11 qtrs — |
| 2 | VR ADVISER, LLC | 5.35M +713.9K (+15.4%) | 28.01M +8.0M (+39.7%) | 5.65% +0.741 pp | 1.38% +0.255 pp | USD2.63 +99.2% | 7 qtrs — |
| 3 | JPMORGAN CHASE & CO | 4.47M -151.4K (-3.3%) | 23.44M +3.4M (+17.1%) | 4.73% -0.174 pp | 0.00% +0.000 pp | USD1.87 +180.2% | 11 qtrs — |
| 4 | GREAT POINT PARTNERS LLC | 3.82M +— (+0.0%) | 20.00M +3.5M (+21.0%) | 4.04% -0.012 pp | 6.48% -0.330 pp | USD6.00 -12.7% | 11 qtrs — |
| 5 | BRAIDWELL LP | 3.18M +707.6K (+28.6%) | 16.67M +6.0M (+55.6%) | 3.36% +0.741 pp | 0.53% +0.215 pp | USD4.32 +21.3% | 6 qtrs — |
| 6 | PFIZER INC | 2.97M +— (+0.0%) | 15.56M +2.7M (+21.0%) | 3.14% -0.009 pp | 6.58% +3.642 pp | USD2.50 +109.6% | 5 qtrs — |
| 7 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.75M -295.4K (-9.7%) | 14.41M +1.2M (+9.3%) | 2.91% -0.322 pp | 0.02% +0.001 pp | USD4.33 +21.0% | 2 qtrs — |
| 8 | AFFINITY ASSET ADVISORS, LLC | 1.81M +539.3K (+42.3%) | 9.50M +4.0M (+72.2%) | 1.92% +0.566 pp | 0.54% +0.061 pp | USD4.42 +18.6% | 8 qtrs — |
| 9 | ARMISTICE CAPITAL, LLC | 1.56M +— (+0.0%) | 8.17M +1.4M (+21.0%) | 1.65% -0.005 pp | 0.10% -0.003 pp | USD5.81 -9.8% | 11 qtrs — |
| 10 | MORGAN STANLEY | 1.51M +1.3M (+620.7%) | 7.91M +7.0M (+772.2%) | 1.60% +1.374 pp | 0.00% +0.000 pp | USD4.81 +8.9% | 11 qtrs — |
| 11 | SIREN, L.L.C. | 1.30M +1.3M (+100.0%) | 6.81M +6.8M (+100.0%) | 1.37% +1.375 pp | 0.20% +0.203 pp | USD5.24 +0.0% | 1 qtrs NEW |
| 12 | MILLENNIUM MANAGEMENT LLC | 1.03M +443.0K (+75.1%) | 5.41M +2.9M (+111.9%) | 1.09% +0.467 pp | 0.00% +0.001 pp | USD3.19 +64.3% | 6 qtrs — |
| 13 | MARSHALL WACE, LLP | 877.8K +877.8K (+100.0%) | 4.60M +4.6M (+100.0%) | 0.93% +0.928 pp | 0.00% +0.004 pp | USD5.24 +0.0% | 1 qtrs NEW |
| 14 | IKARIAN CAPITAL, LLC | 802.3K -1.3M (-62.4%) | 4.20M -5.0M (-54.5%) | 0.85% -1.413 pp | 0.33% -0.604 pp | USD4.33 +21.0% | 2 qtrs — |
| 15 | JANE STREET GROUP, LLC | 657.9K +446.0K (+210.5%) | 3.45M +2.5M (+275.7%) | 0.70% +0.471 pp | 0.00% +0.000 pp | USD4.41 +18.8% | 3 qtrs — |
| 16 | VANGUARD GROUP INC | 568.1K +51.0K (+9.9%) | 2.98M +737.7K (+32.9%) | 0.60% +0.052 pp | 0.00% +0.000 pp | USD5.23 +0.2% | 11 qtrs — |
| 17 | ADAR1 CAPITAL MANAGEMENT, LLC | 562.1K -90.1K (-13.8%) | 2.95M +121.4K (+4.3%) | 0.59% -0.097 pp | 0.22% -0.049 pp | USD3.34 +56.9% | 6 qtrs — |
| 18 | FMR LLC | 529.3K -2.0K (-0.4%) | 2.77M +473.1K (+20.6%) | 0.56% -0.004 pp | 0.00% +0.000 pp | USD1.06 +394.3% | 11 qtrs — |
| 19 | UBS GROUP AG | 470.5K +165.2K (+54.1%) | 2.47M +1.1M (+86.5%) | 0.50% +0.174 pp | 0.00% +0.000 pp | USD4.55 +15.2% | 8 qtrs — |
| 20 | TWO SIGMA INVESTMENTS, LP | 412.4K +276.1K (+202.6%) | 2.16M +1.6M (+266.2%) | 0.44% +0.292 pp | 0.00% +0.002 pp | USD4.22 +24.2% | 9 qtrs — |
| 21 | GEODE CAPITAL MANAGEMENT, LLC | 404.5K -825.0 (-0.2%) | 2.12M +364.6K (+20.8%) | 0.43% -0.002 pp | 0.00% +0.000 pp | USD5.00 +4.8% | 11 qtrs — |
| 22 | BLACKROCK, INC. | 369.4K +3.7K (+1.0%) | 1.94M +352.1K (+22.2%) | 0.39% +0.003 pp | 0.00% +0.000 pp | USD3.87 +35.4% | 6 qtrs — |
| 23 | CAPTION MANAGEMENT, LLC | 318.0K +318.0K (+100.0%) | 1.67M +1.7M (+100.0%) | 0.34% +0.336 pp | 0.01% +0.011 pp | USD5.24 +0.0% | 1 qtrs NEW |
| 24 | RENAISSANCE TECHNOLOGIES LLC | 303.1K +47.7K (+18.7%) | 1.59M +482.4K (+43.6%) | 0.32% +0.050 pp | 0.00% +0.001 pp | USD2.84 +84.5% | 9 qtrs — |
| 25 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 284.1K +36.4K (+14.7%) | 1.49M +415.9K (+38.8%) | 0.30% +0.038 pp | 0.00% +0.000 pp | USD3.38 +55.0% | 6 qtrs — |
| 26 | BOOTHBAY FUND MANAGEMENT, LLC | 262.3K -561.8K (-68.2%) | 1.37M -2.2M (-61.5%) | 0.28% -0.597 pp | 0.02% -0.031 pp | USD4.33 +21.0% | 2 qtrs — |
| 27 | 683 CAPITAL MANAGEMENT, LLC | 259.2K +259.2K (+100.0%) | 1.36M +1.4M (+100.0%) | 0.27% +0.274 pp | 0.06% +0.059 pp | USD5.24 +0.0% | 1 qtrs NEW |
| 28 | POINT72 ASSET MANAGEMENT, L.P. | 226.8K -499.5K (-68.8%) | 1.19M -2.0M (-62.2%) | 0.24% -0.530 pp | 0.00% -0.004 pp | USD3.63 +44.4% | 7 qtrs — |
| 29 | GOLDMAN SACHS GROUP INC | 216.8K +135.1K (+165.3%) | 1.14M +782.2K (+221.1%) | 0.23% +0.143 pp | 0.00% +0.000 pp | USD4.04 +29.7% | 6 qtrs — |
| 30 | — | 166.5K +166.5K (+100.0%) | 872.5K +872.5K (+100.0%) | 0.18% +0.176 pp | 0.66% +0.664 pp | USD5.24 +0.0% | 1 qtrs NEW |
| 31 | STATE STREET CORP | 156.4K +12.0K (+8.3%) | 819.3K +194.3K (+31.1%) | 0.17% +0.012 pp | 0.00% +0.000 pp | USD4.89 +7.2% | 11 qtrs — |
| 32 | ALBERTA INVESTMENT MANAGEMENT CORP | 133.2K +— (+0.0%) | 698.0K +121.2K (+21.0%) | 0.14% 0.000 pp | 0.00% +0.000 pp | USD1.05 +399.0% | 3 qtrs — |
| 33 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 118.0K +— (+0.0%) | 618.3K +107.4K (+21.0%) | 0.12% 0.000 pp | 0.01% +0.002 pp | USD4.33 +21.0% | 2 qtrs — |
| 34 | NORTHERN TRUST CORP | 100.8K +14.4K (+16.7%) | 528.4K +154.1K (+41.2%) | 0.11% +0.015 pp | 0.00% +0.000 pp | USD4.89 +7.2% | 11 qtrs — |
| 35 | TWO SIGMA ADVISERS, LP | 80.4K -38.7K (-32.5%) | 421.3K -94.4K (-18.3%) | 0.09% -0.041 pp | 0.00% 0.000 pp | USD1.88 +178.7% | 5 qtrs — |
| 36 | JUMP FINANCIAL, LLC | 77.7K +77.7K (+100.0%) | 407.1K +407.1K (+100.0%) | 0.08% +0.082 pp | 0.01% +0.005 pp | USD5.24 +0.0% | 1 qtrs NEW |
| 37 | RBF CAPITAL, LLC | 68.2K -11.8K (-14.8%) | 357.3K +10.9K (+3.2%) | 0.07% -0.013 pp | 0.02% +0.000 pp | USD1.05 +399.0% | 3 qtrs — |
| 38 | OMERS ADMINISTRATION CORP | 67.2K +67.2K (+100.0%) | 352.1K +352.1K (+100.0%) | 0.07% +0.071 pp | 0.00% +0.003 pp | USD5.24 +0.0% | 1 qtrs NEW |
| 39 | XTX TOPCO LTD | 66.5K +66.5K (+100.0%) | 348.2K +348.2K (+100.0%) | 0.07% +0.070 pp | 0.01% +0.009 pp | USD5.24 +0.0% | 1 qtrs NEW |
| 40 | CITADEL ADVISORS LLC | 64.0K +32.2K (+101.3%) | 335.4K +197.7K (+143.6%) | 0.07% +0.034 pp | 0.00% +0.000 pp | USD4.79 +9.4% | 5 qtrs — |
| 41 | HUDSON BAY CAPITAL MANAGEMENT LP | 63.1K +63.1K (+100.0%) | 330.6K +330.6K (+100.0%) | 0.07% +0.067 pp | 0.00% +0.001 pp | USD5.24 +0.0% | 1 qtrs NEW |
| 42 | DAUNTLESS INVESTMENT GROUP, LLC | 61.0K +61.0K (+100.0%) | 319.7K +319.7K (+100.0%) | 0.06% +0.065 pp | 0.25% +0.254 pp | USD5.24 +0.0% | 1 qtrs NEW |
| 43 | QUBE RESEARCH & TECHNOLOGIES LTD | 59.9K +27.9K (+87.5%) | 313.7K +175.4K (+126.8%) | 0.06% +0.029 pp | 0.00% +0.000 pp | USD4.75 +10.3% | 2 qtrs — |
| 44 | INSIGNEO ADVISORY SERVICES, LLC | 55.7K +55.7K (+100.0%) | 291.6K +291.6K (+100.0%) | 0.06% +0.059 pp | 0.02% +0.021 pp | USD5.24 +0.0% | 1 qtrs NEW |
| 45 | ALPS ADVISORS INC | 53.4K +53.4K (+100.0%) | 279.8K +279.8K (+100.0%) | 0.06% +0.057 pp | 0.00% +0.002 pp | USD5.24 +0.0% | 1 qtrs NEW |
| 46 | ACADIAN ASSET MANAGEMENT LLC | 52.0K -13.9K (-21.0%) | 271.0K -14.0K (-4.9%) | 0.06% -0.015 pp | 0.00% 0.000 pp | USD2.10 +149.5% | 3 qtrs — |
| 47 | BOXER CAPITAL MANAGEMENT, LLC | 50.0K +50.0K (+100.0%) | 262.0K +262.0K (+100.0%) | 0.05% +0.053 pp | 0.06% +0.057 pp | USD5.24 +0.0% | 1 qtrs NEW |
| 48 | BARCLAYS PLC | 48.7K -15.4K (-24.0%) | 255.0K -5.1K (-2.0%) | 0.05% -0.017 pp | 0.00% +0.000 pp | USD4.33 +21.0% | 11 qtrs — |
| 49 | EXODUSPOINT CAPITAL MANAGEMENT, LP | 46.9K +46.9K (+100.0%) | 245.9K +245.9K (+100.0%) | 0.05% +0.050 pp | 0.00% +0.002 pp | USD5.24 +0.0% | 1 qtrs NEW |
| 50 | CITIGROUP INC | 39.8K +39.7K (+69,652.6%) | 208.3K +208.1K (+84,247.0%) | 0.04% +0.042 pp | 0.00% +0.000 pp | USD5.24 +0.0% | 11 qtrs — |
| 51 | MARINER, LLC | 36.6K -2.1K (-5.5%) | 191.9K +24.0K (+14.3%) | 0.04% -0.002 pp | 0.00% +0.000 pp | USD2.94 +78.2% | 3 qtrs — |
| 52 | QUADRATURE CAPITAL LTD | 36.6K +36.6K (+100.0%) | 191.6K +191.6K (+100.0%) | 0.04% +0.039 pp | 0.00% +0.002 pp | USD5.24 +0.0% | 3 qtrs — |
| 53 | SQUAREPOINT OPS LLC | 33.8K +8.7K (+34.6%) | 177.1K +68.3K (+62.8%) | 0.04% +0.009 pp | 0.00% +0.000 pp | USD4.56 +14.9% | 6 qtrs — |
| 54 | SIMPLEX TRADING, LLC | 31.2K +31.2K (+100.0%) | 163.3K +163.3K (+100.0%) | 0.03% +0.033 pp | 0.00% +0.000 pp | USD5.24 +0.0% | 1 qtrs NEW |
| 55 | RAYMOND JAMES FINANCIAL INC | 26.5K -50.1K (-65.4%) | 138.9K -192.8K (-58.1%) | 0.03% -0.053 pp | 0.00% 0.000 pp | USD2.50 +109.6% | 5 qtrs — |
| 56 | DIMENSIONAL FUND ADVISORS LP | 23.5K +23.5K (+100.0%) | 123.3K +123.3K (+100.0%) | 0.02% +0.025 pp | 0.00% +0.000 pp | USD5.24 +0.0% | 1 qtrs NEW |
| 57 | LIGHTHOUSE INVESTMENT PARTNERS, LLC | 21.7K +21.7K (+100.0%) | 113.5K +113.5K (+100.0%) | 0.02% +0.023 pp | 0.00% +0.003 pp | USD5.24 +0.0% | 1 qtrs NEW |
| 58 | AMERICAN CENTURY COMPANIES INC | 21.4K +21.4K (+100.0%) | 112.0K +112.0K (+100.0%) | 0.02% +0.023 pp | 0.00% +0.000 pp | USD5.24 +0.0% | 1 qtrs NEW |
| 59 | FOREFRONT ANALYTICS, LLC | 19.6K -1.9K (-9.0%) | 102.6K +9.4K (+10.1%) | 0.02% -0.002 pp | 0.09% +0.001 pp | USD2.49 +110.4% | 10 qtrs — |
| 60 | BNP PARIBAS ARBITRAGE, SNC | 18.8K +8.1K (+75.4%) | 98.3K +52.0K (+112.3%) | 0.02% +0.009 pp | 0.00% +0.000 pp | USD3.25 +61.2% | 5 qtrs — |
| 61 | ABEL HALL, LLC | 13.2K +— (+0.0%) | 69.1K +12.0K (+21.0%) | 0.01% +0.000 pp | 0.02% -0.007 pp | USD1.05 +399.0% | 3 qtrs — |
| 62 | BANK OF MONTREAL /CAN/ | 10.0K +10.0K (+100.0%) | 52.4K +52.4K (+100.0%) | 0.01% +0.011 pp | 0.00% +0.000 pp | USD5.24 +0.0% | 1 qtrs NEW |
| 63 | TOWER RESEARCH CAPITAL LLC (TRC) | 8.3K +8.1K (+4,351.6%) | 43.4K +42.6K (+5,289.7%) | 0.01% +0.009 pp | 0.00% +0.001 pp | USD5.16 +1.6% | 12 qtrs — |
| 64 | ALLWORTH FINANCIAL LP | 5.8K +5.8K (+100.0%) | 30.1K +30.1K (+100.0%) | 0.01% +0.006 pp | 0.00% +0.000 pp | USD5.24 +0.0% | 1 qtrs NEW |
| 65 | BANK OF AMERICA CORP /DE/ | 4.4K -6.8K (-60.8%) | 23.0K -25.6K (-52.6%) | 0.00% -0.007 pp | 0.00% +0.000 pp | USD4.48 +17.0% | 11 qtrs — |
| 66 | MAI CAPITAL MANAGEMENT | 4.0K +— (+0.0%) | 21.0K +3.6K (+21.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.50 +109.6% | 5 qtrs — |
| 67 | ROYAL BANK OF CANADA | 2.2K +1.7K (+376.4%) | 11.0K +9.0K (+450.0%) | 0.00% +0.002 pp | 0.00% +0.000 pp | USD5.05 +3.8% | 7 qtrs — |
| 68 | STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 1.0K +— (+0.0%) | 5.2K +910.0 (+21.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD4.33 +21.0% | 2 qtrs — |
| 69 | NISA INVESTMENT ADVISORS, LLC | 702.00 -504.0 (-41.8%) | 3.7K -1.5K (-29.6%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD1.25 +319.2% | 7 qtrs — |
| 70 | GROUP ONE TRADING, L.P. | 200.00 +200.0 (+100.0%) | 1.0K +1.0K (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.24 +0.0% | 1 qtrs NEW |
| 71 | CWM, LLC | 142.00 -696.0 (-83.1%) | 1.0K -3.0K (-75.0%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD1.60 +227.5% | 7 qtrs — |
| 72 | SBI SECURITIES CO., LTD. | 138.00 -1.4K (-90.8%) | 723.00 -5.8K (-88.9%) | 0.00% -0.002 pp | 0.00% 0.000 pp | USD4.03 +30.0% | 5 qtrs — |
| 73 | SRS CAPITAL ADVISORS, INC. | 24.00 -12.0 (-33.3%) | 126.00 -29.0 (-18.7%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD4.29 +22.1% | 2 qtrs — |
| 74 | OPTIVER HOLDING B.V. | 16.00 +— (+0.0%) | 84.00 +15.0 (+21.7%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD4.31 +21.6% | 2 qtrs — |
| 75 | FOREFRONT WEALTH PARTNERS, LLC | — -21.5K (-100.0%) | — -93.2K (-100.0%) | 0.00% -0.023 pp | 0.00% -0.024 pp | USD— | 2 qtrs SOLD |
| 76 | DEEP TRACK CAPITAL, LP | — -259.0K (-100.0%) | — -1.1M (-100.0%) | 0.00% -0.275 pp | 0.00% -0.031 pp | USD— | 11 qtrs SOLD |
| 77 | SAVANT CAPITAL, LLC | — -19.0K (-100.0%) | — -82.2K (-100.0%) | 0.00% -0.020 pp | 0.00% -0.001 pp | USD— | 4 qtrs SOLD |
| 78 | DLD ASSET MANAGEMENT, LP | — -15.2K (-100.0%) | — -65.7K (-100.0%) | 0.00% -0.016 pp | 0.00% -0.003 pp | USD— | 2 qtrs SOLD |
| 79 | SCIENTECH RESEARCH LLC | — -10.4K (-100.0%) | — -44.9K (-100.0%) | 0.00% -0.011 pp | 0.00% -0.016 pp | USD— | 2 qtrs SOLD |
| 80 | SILVERARC CAPITAL MANAGEMENT, LLC | — -720.5K (-100.0%) | — -3.1M (-100.0%) | 0.00% -0.764 pp | 0.00% -0.421 pp | USD— | 2 qtrs SOLD |
| 81 | AQR CAPITAL MANAGEMENT LLC | — -44.2K (-100.0%) | — -191.5K (-100.0%) | 0.00% -0.047 pp | 0.00% 0.000 pp | USD— | 7 qtrs SOLD |
| 82 | ATIKA CAPITAL MANAGEMENT LLC | — -276.0K (-100.0%) | — -1.2M (-100.0%) | 0.00% -0.293 pp | 0.00% -0.096 pp | USD— | 2 qtrs SOLD |
| 83 | AMERIPRISE FINANCIAL INC | — -500.0K (-100.0%) | — -2.2M (-100.0%) | 0.00% -0.530 pp | 0.00% -0.001 pp | USD— | 2 qtrs SOLD |
| 84 | TRUE WEALTH DESIGN, LLC | — -78.0 (-100.0%) | — -338.0 (-100.0%) | 0.00% 0.000 pp | 0.00% 0.000 pp | USD— | 4 qtrs SOLD |
| 85 | JONES FINANCIAL COMPANIES LLLP | — -1.4K (-100.0%) | — -3.3K (-100.0%) | 0.00% -0.002 pp | 0.00% +0.000 pp | USD— | 4 qtrs SOLD |
| 86 | CLEAR STREET GROUP INC. | — -1.7K (-100.0%) | — -7.3K (-100.0%) | 0.00% -0.002 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 4 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | ALPS Medical Breakthroughs ETF SBIO | 0.25% | 530.1K | 0.50% |
| 2 | Global X - Russell 2000 ETF RSSL | 0.01% | 140.3K | 0.08% |
| 3 | iShares U.S. Small Cap Index ETF (CAD-Hedged) XSU.TO | 0.01% | 49.6K | 0.36% |
| 4 | Vanguard Extended Market ETF VXF | 0.00% | 2.04M | 0.05% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
5
Sells
0
Shares acquired
2.26M
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+2,264,500
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-01 | Whale Gary | Officer | A-Award | A | Employee Share Option (Right to Buy) | 263,000 | 6.03 | 1.59M | 263,000 | D | ↗ |
| 2026-04-01 | Nistala Kiran | Officer | A-Award | A | Employee Share Option (Right to Buy) | 340,900 | 6.03 | 2.06M | 340,900 | D | ↗ |
| 2026-04-01 | Kulkarni Sandeep Chidambar | Director / Officer | A-Award | A | Employee Share Option (Right to Buy) | 894,000 | 6.03 | 5.39M | 894,000 | D | ↗ |
| 2026-04-01 | Hyllengren Eric J | Officer | A-Award | A | Employee Share Option (Right to Buy) | 340,900 | 6.03 | 2.06M | 340,900 | D | ↗ |
| 2026-04-01 | Davis Kim | Officer | A-Award | A | Employee Share Option (Right to Buy) | 425,700 | 6.03 | 2.57M | 425,700 | D | ↗ |
| 2026-02-26 | AI Biotechnology LLC | 10% Owner | P-Purchase | A | Class A Ordinary Shares | 2,000,000 | 6.25 | 12.50M | 6,552,725 | D | ↗ |
| 2026-02-21 | Nirula Ajay | Director | A-Award | A | Share Option (Right to Buy) | 37,812 | 6.53 | 246.9K | 37,812 | D | ↗ |
| 2026-02-21 | Eisner Mark | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2026-01-23 | Thiara Parvinder | Director | — | — | Share Option (Right to Buy) | 48,149 | 3.98 | 191.6K | 0 | D | ↗ |
| 2026-01-21 | Kulkarni Sandeep Chidambar | Director / Officer | A-Award | A | Employee Share Option (Right to Buy) | 2,934,107 | 6.32 | 18.54M | 2,934,107 | D | ↗ |
| 2025-12-29 | Athanor Capital | 10% Owner | — | — | Class A Ordinary Shares, par value $0.0001 per share | 0 | 0.00 | — | 11,581,402 | D | ↗ |
| 2025-07-15 | Hyllengren Eric J | Officer | A-Award | A | Employee Share Option (Right to Buy) | 672,000 | 1.30 | 873.6K | 672,000 | D | ↗ |
| 2025-07-07 | Hyllengren Eric J | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-05-29 | Becker Daniel J. | Director | A-Award | A | Share Option (Right to Buy) | 51,000 | 1.02 | 52.0K | 51,000 | D | ↗ |
| 2025-05-21 | Sidhu Someit | Director | A-Award | A | Share Option (Right to Buy) | 51,000 | 1.03 | 52.5K | 51,000 | D | ↗ |
| 2025-05-21 | Schoch Steven J | Director | A-Award | A | Share Option (Right to Buy) | 51,000 | 1.03 | 52.5K | 51,000 | D | ↗ |
| 2025-05-21 | Ploos van Amstel Arnout | Director | A-Award | A | Share Option (Right to Buy) | 51,000 | 1.03 | 52.5K | 51,000 | D | ↗ |
| 2025-05-21 | Munshi Amit | Director | A-Award | A | Share Option (Right to Buy) | 51,000 | 1.03 | 52.5K | 51,000 | D | ↗ |
| 2025-05-21 | Kulkarni Sandeep Chidambar | Director | A-Award | A | Share Option (Right to Buy) | 51,000 | 1.03 | 52.5K | 51,000 | D | ↗ |
| 2025-05-21 | Jarrett Jennifer | Director | A-Award | A | Share Option (Right to Buy) | 51,000 | 1.03 | 52.5K | 51,000 | D | ↗ |
| 2025-05-21 | Graham Neil Murray Hamilton | Director | A-Award | A | Share Option (Right to Buy) | 51,000 | 1.03 | 52.5K | 51,000 | D | ↗ |
| 2025-05-21 | Becker Daniel J. | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-05-21 | AI Biotechnology LLC | 10% Owner | — | — | Class A Ordinary Shares | 0 | 0.00 | — | 4,552,725 | D | ↗ |
| 2025-05-08 | Badial Verender S. | Officer | A-Award | A | Employee Share Option (Right to Buy) | 303,100 | 1.26 | 381.9K | 303,100 | D | ↗ |
| 2025-02-27 | Whale Gary | Officer | A-Award | A | Employee Share Option (Right to Buy) | 302,000 | 1.20 | 362.4K | 302,000 | D | ↗ |
| 2025-02-27 | Nistala Kiran | Officer | A-Award | A | Employee Share Option (Right to Buy) | 341,700 | 1.20 | 410.0K | 341,700 | D | ↗ |
| 2025-02-27 | Lisicki Robert | Director / Officer | A-Award | A | Employee Share Option (Right to Buy) | 1,153,000 | 1.20 | 1.38M | 1,153,000 | D | ↗ |
| 2025-02-27 | Davis Kim | Officer | A-Award | A | Employee Share Option (Right to Buy) | 488,800 | 1.20 | 586.6K | 488,800 | D | ↗ |
| 2024-12-31 | Sidhu Someit | Director | — | — | Class A Ordinary Shares | 0 | 0.00 | — | 1,186,901 | I | ↗ |
| 2024-12-09 | Thiara Parvinder | Director | A-Award | A | Share Option (Right to Buy) | 117,000 | 2.76 | 322.9K | 117,000 | D | ↗ |
| 2024-12-09 | Sidhu Someit | Director | A-Award | A | Share Option (Right to Buy) | 117,000 | 2.76 | 322.9K | 117,000 | D | ↗ |
| 2024-12-09 | Schoch Steven J | Director | A-Award | A | Share Option (Right to Buy) | 117,000 | 2.76 | 322.9K | 117,000 | D | ↗ |
| 2024-12-09 | Ploos van Amstel Arnout | Director | A-Award | A | Share Option (Right to Buy) | 117,000 | 2.76 | 322.9K | 117,000 | D | ↗ |
| 2024-12-09 | Munshi Amit | Director | A-Award | A | Share Option (Right to Buy) | 117,000 | 2.76 | 322.9K | 117,000 | D | ↗ |
| 2024-12-09 | Lisicki Robert | Director / Officer | A-Award | A | Employee Share Option (Right to Buy) | 117,000 | 2.76 | 322.9K | 117,000 | D | ↗ |
| 2024-12-09 | Kulkarni Sandeep Chidambar | Director | A-Award | A | Share Option (Right to Buy) | 117,000 | 2.76 | 322.9K | 117,000 | D | ↗ |
| 2024-12-09 | Jarrett Jennifer | Director | A-Award | A | Share Option (Right to Buy) | 117,000 | 2.76 | 322.9K | 117,000 | D | ↗ |
| 2024-12-09 | Graham Neil Murray Hamilton | Director | A-Award | A | Share Option (Right to Buy) | 117,000 | 2.76 | 322.9K | 117,000 | D | ↗ |
| 2024-11-25 | Thiara Parvinder | Director | S-Sale | D | Class A Ordinary Shares | 1,001,633 | 2.73 | 2.73M | 0 | I | ↗ |
| 2024-09-16 | Davis Kim | Officer | A-Award | A | Class A Ordinary Shares | 1,000 | 0.00 | — | 1,500 | I | ↗ |
| 2024-09-11 | Thiara Parvinder | Director | S-Sale | D | Class A Ordinary Shares | 3,800,000 | 2.70 | 10.26M | 1,001,633 | — | ↗ |
| 2024-09-04 | Sidhu Someit | Director | S-Sale | D | Class A ordinary shares | 51,728 | 3.87 | 200.2K | 2,085,418 | — | ↗ |
| 2024-08-23 | Sidhu Someit | Director | D-Return | D | Warrants | 2,406,573 | 11.50 | 27.68M | 0 | D | ↗ |
| 2024-08-23 | Badial Verender S. | Officer | D-Return | D | Warrants | 420,519 | 11.50 | 4.84M | 0 | D | ↗ |
| 2024-06-18 | Whale Gary | Officer | A-Award | A | Employee Share Option (Right to Buy) | 280,000 | 3.38 | 946.4K | 280,000 | — | ↗ |
| 2024-06-18 | Nistala Kiran | Officer | A-Award | A | Employee Share Option (Right to Buy) | 285,000 | 3.38 | 963.3K | 285,000 | — | ↗ |
| 2024-06-18 | Lisicki Robert | Officer | A-Award | A | Employee Share Option (Right to Buy) | 1,050,000 | 3.38 | 3.55M | 1,050,000 | — | ↗ |
| 2024-06-18 | Howell Michael | Officer | A-Award | A | Employee Share Option (Right to Buy) | 295,000 | 3.38 | 997.1K | 295,000 | — | ↗ |
| 2024-06-18 | Davis Kim | Officer | A-Award | A | Employee Share Option (Right to Buy) | 420,000 | 3.38 | 1.42M | 420,000 | — | ↗ |
| 2024-06-18 | Badial Verender S. | Officer | A-Award | A | Employee Share Option (Right to Buy) | 420,000 | 3.38 | 1.42M | 420,000 | — | ↗ |
| 2024-05-18 | Howell Michael | Officer | F-InKind | D | Class A ordinary shares | 9,860 | 6.05 | 59.7K | 104,535 | — | ↗ |
| 2024-05-17 | Ploos van Amstel Arnout | Director | P-Purchase | A | Class A ordinary shares | 80,000 | 6.20 | 496.0K | 100,000 | — | ↗ |
| 2024-04-22 | Sidhu Someit | Director | A-Award | A | Class A ordinary shares | 1,186,901 | 3.13 | 3.72M | 1,186,901 | — | ↗ |
| 2024-04-22 | Nistala Kiran | Officer | A-Award | A | Class A ordinary shares | 3,195 | 3.13 | 10.0K | 3,195 | — | ↗ |
| 2024-04-22 | Munshi Amit | Director | P-Purchase | A | Class A ordinary shares | 159,744 | 3.13 | 500.0K | 777,384 | — | ↗ |
| 2024-04-22 | Howell Michael | Officer | A-Award | A | Class A ordinary shares | 7,987 | 3.13 | 25.0K | 7,987 | — | ↗ |
| 2024-01-24 | Thiara Parvinder | Director / 10% Owner | A-Award | A | Stock options | 48,149 | 3.98 | 191.6K | 48,149 | — | ↗ |
| 2024-01-24 | Ploos van Amstel Arnout | Director | A-Award | A | Stock options | 48,149 | 3.98 | 191.6K | 48,149 | — | ↗ |
| 2024-01-24 | Nistala Kiran | Officer | A-Award | A | Stock options | 350,000 | 3.98 | 1.39M | 350,000 | — | ↗ |
| 2024-01-24 | Lisicki Robert | Officer | A-Award | A | Stock options | 1,000,000 | 3.98 | 3.98M | 1,000,000 | — | ↗ |
| 2023-10-30 | Sidhu Someit | Director | P-Purchase | A | Warrants | 2,480,000 | 11.50 | 28.52M | 0 | I | ↗ |
| 2023-10-01 | Davis Kim | Officer | A-Award | A | Class A Ordinary Shares | 500 | 0.00 | — | 500 | I | ↗ |
| 2023-09-28 | Sidhu Someit | Director | J-Other | A | Warrants | 656,573 | 11.50 | 7.55M | 0 | D | ↗ |
| 2023-09-28 | Badial Verender S. | Officer | J-Other | A | Warrants | 420,519 | 11.50 | 4.84M | 0 | D | ↗ |
Executive team
Top executives
Shares Outstanding
65.02M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2024 | Robert Lisicki Chief Executive Officer | 537.8K | 316.5K | — | 5.81M | — | — | 6.66M | 87.17% | ↗ |
| 2 | 2024 | Kiran Nistala Chief Medical Officer and Head of Development | 409.6K | 177.4K | — | 1.93M | — | 10.5K | 2.53M | 76.40% | ↗ |
| 3 | 2024 | Kim Davis Chief Operating Officer, Chief Legal Officer and Corporate Secretary | 437.4K | 195.7K | — | 1.14M | — | 20.7K | 1.80M | 63.59% | ↗ |
| 4 | 2024 | Someit Sidhu Former Chief Executive Officer | 148.4K | — | — | — | — | 863.1K | 1.01M | 0.00% | ↗ |
| 5 | 2023 | Someit Sidhu Former Chief Executive Officer | 415.5K | 132.0K | — | 10.20M | — | — | 10.75M | 94.91% | ↗ |
| 6 | 2023 | Kim Davis Chief Operating Officer, Chief Legal Officer and Corporate Secretary | 425.0K | 274.3K | 2.58M | 1.58M | — | 7.4K | 4.87M | 85.48% | ↗ |
| 7 | 2023 | Kiran Nistala Chief Medical Officer and Head of Development | 14.8K | — | — | — | — | — | 14.8K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Kiran Nistala MBBS | Chief Medical Officer & Head of Development | 691.2K | — |
| Kimberly Ann Davis | Chief Operating Officer, Chief Legal Officer & Corporate Secretary | 653.8K | female |
| Eric Hyllengren | Chief Financial Officer | 462.0K | male |
| Sandeep C. Kulkarni | Co-Founder, CEO & Director | 55.6K | — |
| Someit Sidhu | Co-Founder & Director | 46.7K | — |
| Gary Whale | Chief Technology Officer | — | — |
| Theresa Lowry | Chief Human Resources Officer | — | female |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ZURA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
